Microemulsions Enhance the In Vitro Antioxidant Activity of Oleanolic Acid in RAW 264.7 Cells.

LPS PAMPA RAW 264.7 murine macrophages microemulsions oleanolic acid

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
19 Oct 2022
Historique:
received: 12 09 2022
revised: 10 10 2022
accepted: 16 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Oleanolic acid (OA) is the main triterpenic acid of olive leaves known for numerous pharmacological properties, including antioxidant activity. However, it is poorly soluble in water and consequently with low bioavailability, which limits its pharmacological application. Microemulsions (MEs) are dispersed systems consisting of two immiscible phases that promote rapid solubilization and absorption in the gastrointestinal tract. To improve both solubility and intestinal permeability of this molecule, OA has been formulated in two different microemulsions (ME-1 and ME-2). A solubility screening was carried out to select the ME components, and pseudoternary phase diagrams were constructed to evaluate the region of existence and select the appropriate amount of the constituents. ME-1 was prepared using Capmul PG-8/NF as the oily phase, and Transcutol and Tween 20 (7:3) as surfactants, while ME-2 contained Nigella oil and Isopropil myristate as the oily phase, and Transcutol HP and Cremophor EL (2:1) as surfactants. The OA solubility was increased by 1000-fold and 3000-fold in ME-1-OA and ME-2-OA, respectively. The MEs' droplet size and the PdI were evaluated, and the stability was assessed for 8 weeks by monitoring chemical and physical parameters. The parallel artificial membrane permeability assay (PAMPA) also demonstrated an enhanced intestinal permeability of both OA formulations compared with free OA. The potential ability of both MEs to enhance the bioactivity of OA against LPS-induced oxidative stress in RAW 264.7 murine macrophages was also investigated. Overall, this study suggests that both MEs promote a bio-enhancement of the protective action of OA against the LPS-induced pro-oxidant stress in macrophages. Overall, this study suggests that MEs could be an interesting formulation to improve OA oral bioavailability with potential clinical applications.

Identifiants

pubmed: 36297667
pii: pharmaceutics14102232
doi: 10.3390/pharmaceutics14102232
pmc: PMC9610975
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Bio-Based Industries Joint Undertaking under the European Union's Horizon 2020 research and innovation program
ID : 101023256

Références

Int J Pharm. 2017 Jun 30;526(1-2):425-442
pubmed: 28495500
Biomed Res Int. 2020 Nov 25;2020:1308749
pubmed: 33299854
Nanomaterials (Basel). 2021 Oct 26;11(11):
pubmed: 34835622
J Control Release. 2001 Jan 29;70(1-2):149-55
pubmed: 11166415
Drug Discov Today. 2022 Feb;27(2):401-421
pubmed: 34601123
World J Clin Cases. 2020 May 26;8(10):1767-1792
pubmed: 32518769
Expert Opin Drug Deliv. 2017 Nov;14(11):1325-1340
pubmed: 27485144
J Pharm Pharmacol. 2006 Jan;58(1):45-50
pubmed: 16393463
Eur J Pharm Sci. 2005 Apr;24(5):477-86
pubmed: 15784337
Drug Des Devel Ther. 2011;5:311-23
pubmed: 21792294
Immunol Res. 2002;26(1-3):95-105
pubmed: 12403349
Curr Drug Deliv. 2022 May 19;:
pubmed: 35598245
Front Physiol. 2020 Jul 02;11:694
pubmed: 32714204
J Biol Chem. 2002 Jun 21;277(25):22131-9
pubmed: 11940570
Neural Regen Res. 2019 Feb;14(2):238-241
pubmed: 30531003
Biopharm Drug Dispos. 2007 Mar;28(2):51-7
pubmed: 17163409
Curr Drug Deliv. 2019;16(2):142-152
pubmed: 30306869
Molecules. 2017 Nov 13;22(11):
pubmed: 29137205
Curr Drug Deliv. 2006 Apr;3(2):167-80
pubmed: 16611003
Int J Nanomedicine. 2016 Nov 28;11:6337-6352
pubmed: 27932881
Molecules. 2020 Jul 13;25(14):
pubmed: 32668791
J Ethnopharmacol. 1995 Dec 1;49(2):57-68
pubmed: 8847885
Int J Mol Sci. 2013 Aug 28;14(9):17643-63
pubmed: 23989608
Oxid Med Cell Longev. 2016;2016:4350965
pubmed: 26998193
Molecules. 2015 Nov 27;20(12):21138-56
pubmed: 26633317
J Am Chem Soc. 2016 Jan 27;138(3):704-17
pubmed: 26741786
J Biol Chem. 2014 Mar 14;289(11):7884-96
pubmed: 24492615
Expert Opin Drug Deliv. 2017 Jun;14(6):755-768
pubmed: 27606793
Front Chem. 2022 May 11;10:890252
pubmed: 35646816
Int J Nanomedicine. 2013;8:2917-26
pubmed: 23966781
Pharm Res. 1995 Nov;12(11):1561-72
pubmed: 8592652
Evid Based Complement Alternat Med. 2014;2014:651593
pubmed: 24971152
Nanoscale Res Lett. 2020 Jun 22;15(1):133
pubmed: 32572634
Chem Biol Interact. 2010 Mar 30;184(3):328-37
pubmed: 20100471
AAPS PharmSciTech. 2009;10(1):172-82
pubmed: 19224372
J Ethnopharmacol. 2020 Jan 30;247:112252
pubmed: 31562953
Eur J Pharm Sci. 2022 Feb 1;169:106090
pubmed: 34864170
J Food Drug Anal. 2017 Jan;25(1):111-118
pubmed: 28911528
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Pharmaceutics. 2022 Mar 11;14(3):
pubmed: 35335992
Molecules. 2022 May 09;27(9):
pubmed: 35566392
Life Sci. 2021 Jul 1;276:119420
pubmed: 33785340
J Control Release. 2009 Dec 3;140(2):86-94
pubmed: 19709639
Colloids Surf B Biointerfaces. 2015 Jun 1;130:40-7
pubmed: 25899842
Nutrients. 2022 Jan 31;14(3):
pubmed: 35276982
Pharmaceutics. 2021 Dec 28;14(1):
pubmed: 35056964
Molecules. 2009 Jun 04;14(6):2016-31
pubmed: 19513002
Eur J Pharm Sci. 2002 Sep;16(4-5):237-46
pubmed: 12208453
Int J Pharm. 2001 Jan 16;212(2):233-46
pubmed: 11165081
Int J Pharm. 2012 Aug 20;433(1-2):25-33
pubmed: 22579578
Toxicol Sci. 2008 May;103(1):149-57
pubmed: 18281254
Int J Pharm. 2006 Feb 3;308(1-2):84-9
pubmed: 16330171
Int J Pharm. 2008 Mar 20;352(1-2):231-9
pubmed: 18068919
Int J Pharm. 2002 Oct 10;246(1-2):85-94
pubmed: 12270611
Eur J Pharm Sci. 2006 Nov;29(3-4):278-87
pubmed: 16815001
Expert Opin Drug Deliv. 2010 Apr;7(4):445-60
pubmed: 20201713
J Pharm Sci. 2014 Nov;103(11):3491-3500
pubmed: 25103361
Adv Pharm Bull. 2015 Sep;5(3):305-13
pubmed: 26504751
J Cosmet Sci. 2020 Jan/Feb;71(1):23-36
pubmed: 32271706
Planta Med. 2018 Aug;84(12-13):976-984
pubmed: 29689586

Auteurs

Chiara De Stefani (C)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.

Marzia Vasarri (M)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Viale Morgagni 50, 50134 Florence, Italy.

Maria Cristina Salvatici (MC)

Institute of Chemistry of Organometallic Compounds (ICCOM)-Electron Microscopy Centre (Ce.M.E.), National Research Council (CNR), Via Madonna del Piano 10, 50019 Sesto Fiorentino, Italy.

Lucia Grifoni (L)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.

Jose Carlos Quintela (JC)

NATAC BIOTECH, Electronica 7, Alcorcón, 28923 Madrid, Spain.

Anna Rita Bilia (AR)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.

Donatella Degl'Innocenti (D)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Viale Morgagni 50, 50134 Florence, Italy.

Maria Camilla Bergonzi (MC)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.

Classifications MeSH